← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
The General Hospital Corporation
$431,038,412
Total funding
302
Grants
Funding over time
peak $66.5M · FY2008–25$100M$75M$50M$25M$0
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
DOD$416,219,287 · 282
NASA$12,358,085 · 15
DOE$2,093,134 · 2
USDA$367,906 · 3
By mechanism
—$431,038,412 · 302
Investigators at The General Hospital Corporation
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
Not enough data
All-Time
Most funded here, all years
Not enough data
Largest grants
THE CENTER FOR INTEGRATION OF MEDICINE AND INNOVATIVE TECHNOLOGY (CIMIT)$28,901,977
· FY2009 · Department of Defense
TRANSFORMATIVE RESTORATION OF AFFECTIVE NETWORKS BY SYSTEMATIC, FUNCTION-ORIENTED, REAL-TIME MODELING AND DEEP BRANIN STIMULATION (TRANSFORM DBS)$23,644,724
· FY2014 · Department of the Army
"MEDICAL FREE ELECTRON LASER PROGRAM", REVISED 10 OCT 03$23,476,591
· FY2008 · Department of the Air Force
TAS::97 0130::TAS '(FY16 DHP MIL MED PHOTONICS) NEW IN 2017 MILITARY MEDICAL PHOTONICS PROGRAM AT THE WELLMAN CENTER FOR PHOTOMEDICINE'$20,593,781
· FY2017 · Department of the Air Force
THE CENTER FOR INTEGRATION OF MEDICINE ND INNOVATIVE TECHNOLOGY$20,062,201
· FY2008 · Department of Defense
THE PURPOSE OF THIS COOPERATIVE AGREEMENT IS TO FUND RESEARCH IN SUPPORT OF BTO IN THE AMOUNT OF 987,271 ON CONTRACT HR0011-17-2-0042.$15,806,840
· FY2017 · Defense Advanced Research Projects Agency
STRATEGIES FOR PERSONALIZED TREATMENT OF METASTATIC BREAST CANCER: VASCULAR NORMALIZATION AND SENSITIZATION$8,845,803
· FY2010 · Department of Defense
TAS::97 3600::TAS 'MILITARY MEDICAL PHOTONICS PROGRAM AT THE WELLMAN CENTER FOR PHOTOMEDICINE' DATED 13 MAY 2013; REVISED 26 SEP 2013$8,766,385
· FY2014 · Department of the Air Force
DEVELOPING MEMORY RECONSOLIDATION BLOCKERS AS NOVEL PTSD TREATMENTS$6,651,173
· FY2008 · Department of the Army
IMPROVING JOINT FUNCTION USING PHOTOCHEMICAL HYDROGELS FOR ARTICULAR SURFACE REPAIR$6,029,398
· FY2010 · Department of Defense
NO COST EXTENSION. MASSACHUSETTS GENERAL HOSPITAL. THIS ACTION IS A ONE MONTH NO COST EXTENSION THROUGH 26 OCTOBER 2013.$6,008,342
· FY2014 · Department of Defense
LYOPHILIZED INJECTABLE FOR POINT-OF-CARE THERAPEUTIC FOR POST-TRAUMATIC OSTEOARTHRITIS$5,669,320
· FY2017 · Defense Health Agency
TAS::97 0130::TAS "RESEARCH TO DEVELOP AND APPLY BIOPHOTONICS TO MILITARY MEDICINE NEEDS" (THE GRANTEE'S TECHNICAL PROPOSAL) DATED 21 APR 1$5,235,236
· FY2011 · Department of Defense
GENETICALLY MODIFIED PORCINE SKIN GRAFTS FOR TREATMENT OF SEVERE BURN INJURIES$4,739,367
· FY2009 · Department of the Army
A MIXED MODALITY APPROACH TO TREATING RETT SYNDROME$4,241,328
· FY2019 · Department of the Army
B7-H3-SPECIFIC CHIMERIC ANTIGEN RECEPTOR (CAR) T-CELL IMMUNOTHERAPY FOR METASTATIC TRIPLE-NEGATIVE BREAST CANCER (MTNBC)$4,004,834
· FY2020 · Defense Health Agency
ASSESSMENT OF CIRCULATORY DYSFUNCTION BY AUTOMATED PROCESSING OF VITAL SIGNS DATA$3,798,685
· FY2012 · Department of the Army
PILOT TRIAL OF BARICITINIB FOR ALS PATIENTS AND ASYMPTOMATIC MUTANT C9ORF72 CARRIERS INCLUDING NOVEL PERIPHERAL IMMUNE CELL PROFILING AND CSF BIOMARKERS$3,356,704
· FY2022 · Defense Health Agency
B7-H3-SPECIFIC CHIMERIC ANTIGEN RECEPTOR (CAR) T-CELL IMMUNOTHERAPY FOR METASTATIC TRIPLE-NEGATIVE BREAST CANCER (MTNBC)$3,246,139
· FY2020 · Defense Health Agency
AUTONOMOUS CASUALTY SIMULATOR (COMETS)$3,148,113
· FY2008 · Department of the Army